EPISODE · Mar 11, 2025 · 34 MIN
NRG-GU012, the SAMURAI Study, with Dr. William A. Hall
from The NRG Oncology Podcast · host NRG Oncology
Our co-hosts discuss the currently active & accruing NRG-GU012 study, also known as the "SAMURAI" study. This study is assessing if stereotactic ablative radiotherapy to the primary tumor in combination with immunotherapy improves outcomes when compared to immunotherapy by itself for patients who have metastatic, unresected, renal cell carcinoma.
What this episode covers
Our co-hosts discuss the currently active & accruing NRG-GU012 study, also known as the "SAMURAI" study. This study is assessing if stereotactic ablative radiotherapy to the primary tumor in combination with immunotherapy improves outcomes when compared to immunotherapy by itself for patients who have metastatic, unresected, renal cell carcinoma.
NOW PLAYING
NRG-GU012, the SAMURAI Study, with Dr. William A. Hall
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m